Back
Cytek Biosciences Quote, Financials, Valuation and Earnings
Sell
16
CTKB
Cytek Biosciences
Last Price:
6.10
Seasonality Move:
42.11%
7 Day Trial
ALL ACCESS PASS
$
7
Cytek Biosciences Price Quote
$6.10
Cytek Biosciences Key Stats
Sell
16
Cytek Biosciences (CTKB)
is a Sell
Day range:
$5.91 - $6.26
52-week range:
$3.80 - $9.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.08
P/B ratio:
2.04%
Volume:
560.9K
Avg. volume:
711.5K
1-year change:
-11.08%
Market cap:
$800.8M
Revenue:
$193M
EPS:
$-0.09
How Much Does Cytek Biosciences Make?
-
How Much Are Cytek Biosciences's Sales Annually?
CTKB Revenues are $193M -
How Much Profit Does Cytek Biosciences's Make A Year?
CTKB net income is -$12.1M
Is Cytek Biosciences Growing As A Company?
-
What Is Cytek Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.21% -
What Is Cytek Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cytek Biosciences Stock Price Performance
-
Did Cytek Biosciences Stock Go Up Last Month?
Cytek Biosciences share price went up by 3.04% last month -
Did CTKB's Share Price Rise Over The Last Year?
CTKB share price fell by -11.08% over the past 1 year
What Is Cytek Biosciences 52-Week High & Low?
-
What Is Cytek Biosciences’s 52-Week High Share Price?
Cytek Biosciences has traded as high as $9.87 over the past 52 weeks -
What Is Cytek Biosciences’s 52-Week Low Share Price?
Cytek Biosciences has traded as low as $3.80 over the past 52 weeks
Cytek Biosciences Price To Free Cash Flow
-
Is Cytek Biosciences Stock Overvalued?
Cytek Biosciences is trading at a price to free cash flow ratio of 569.81 -
Is Cytek Biosciences Stock Undervalued?
Cytek Biosciences EV to Free Cash Flow ratio is 371.93 -
What Is Cytek Biosciences’s Price Earnings Growth Ratio?
CTKB PEG ratio is -0.13 -
Is Cytek Biosciences Trading At A Premium To Earnings?
Cytek Biosciences EV to EBIT ratio is 0.00
Is It Risky To Buy Cytek Biosciences?
-
How Much Debt Does Cytek Biosciences Have?
Total long term debt quarterly is $3.4M -
How Much Cash Does Cytek Biosciences Have?
Cash and short term investments quarterly total is $270.1M -
What Is Cytek Biosciences’s Book Value Per Share?
Book value per share is 2.99
Is Cytek Biosciences Cash Flow Positive?
-
What Is CTKB Cash Flow From Operations?
Cash flow from operations (TTM) is $6.4M -
What Is Cytek Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$40.2M -
What Is Cytek Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $69.2M
Cytek Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
CTKB return on invested capital is -2.79% -
What Is Cytek Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -2.25% -
What Is CTKB Return On Equity?
ROE is a measure of profitability and is -2.81%
Cytek Biosciences Earnings Date & Stock Price
-
What Is Cytek Biosciences's Stock Price Today?
A single share of CTKB can be purchased today for 6.10 -
What Is Cytek Biosciences’s Stock Symbol?
Cytek Biosciences trades on the nasdaq under the ticker symbol: CTKB -
When Is Cytek Biosciences’s Next Earnings Date?
The next quarterly earnings date for Cytek Biosciences is scheduled on August 8, 2024 -
When Is CTKB's next ex-dividend date?
Cytek Biosciences's next ex-dividend date is May 19, 2024 -
How To Buy Cytek Biosciences Stock?
You can buy Cytek Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cytek Biosciences Competitors
-
Who Are Cytek Biosciences's Competitors?
Below is a list of companies who compete with Cytek Biosciences or are related in some way:
Cytek Biosciences Dividend Yield
Data Unavailable
Cytek Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 20.96% | 2.92% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 9.80 |
| Upside from Last Price: | 60.66% |